|
VRSA Á¤ÀÇ, Ư¡, Áõ»ó ¹× ¿¹¹æ¹æ¹ý¿¡ ´ëÇÑ ·¹Æ÷Æ®ÀÔ´Ï´Ù. / 1. VRSA(vancomycin resistant Staphylococcus aureus_¹ÝÄÚ¸¶À̽ų»¼ºÈ²»öÆ÷µµ¾Ë±Õ) Á¤ÀÇ 2. VRSA Ư¡ 3. VRSA¹ß»ýÇöȲ 4. VRSA Áõ»ó ¹× °¨¿°°æ·Î 5. VRSA Áø´Ü ¹× ¿¹¹æ 6. Âü°íÀÚ·á / 1. VRSA(vancomycin resistant Staphylococcus aureus_¹ÝÄÚ¸¶À̽ų»¼ºÈ²»öÆ÷µµ¾Ë±Õ) Á¤ÀÇ 2. VRSA Ư¡ 3. VRSA¹ß»ýÇöȲ 4. VRSA Áõ»ó ¹×¡¦ |
|
|
|
|
|
Vroom°ú YettonÀÇ Âü¿©Àû ¸®´õ½ÊÀÌ·Ð À̵éÀº ¸®´õÀÇ ÀÇ»ç°áÁ¤¿¡ ÃÊÁ¡À» ¸ÂÃá »óȲÀû ¸®´õ½ÊÀÌ·ÐÀ» ÁÖÀåÇÏ¿´´Ù. ÀÌ À̷п¡¼´Â È¿°úÀûÀÎ ¸®´õ.. / Vroom°ú YettonÀÇ Âü¿©Àû ¸®´õ½ÊÀÌ·Ð À̵éÀº ¸®´õÀÇ ÀÇ»ç°áÁ¤¿¡ ÃÊÁ¡À» ¸ÂÃá »óȲÀû ¸®´õ½ÊÀÌ·ÐÀ» ÁÖÀåÇÏ¿´´Ù. ÀÌ À̷п¡¼´Â È¿°úÀûÀÎ ¸®´õ°¡ µÇ±â À§Çؼ´Â `ÁÁÀº ÀÇ»ç°áÁ¤` À» ÇØ¾ß ÇÑ´Ù´Â Á¡À» °Á¶ÇÏ°í Àִµ¥, °æ¿µÀÚµéÀÇ Áß¿äÇÑ ¿ªÇÒ¡¦ |
|
|
|
|
|
ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð ¸ñÂ÷ ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð I. Èû II. À¯Àΰ¡ III. ±â´ë IV. °á°ú V. ¼ö´Ü¼º VI.. / ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð ¸ñÂ÷ ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð I. Èû II. À¯Àΰ¡ III. ±â´ë IV. °á°ú V. ¼ö´Ü¼º VI. ÇàÀ§ Âü°í¹®Çå ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð ºê·ë(Vroom, 1964)ÀÌ Á¦½ÃÇÑ ±â´ëÀÌ·Ð(Expectancy Theory)¿¡¼´Â µ¿±â¸¦ »ç¶÷ ¾È¿¡ ÀÖ´Â Èû ¶Ç´Â Ã浿À¸·Î¡¦ |
|
|
|
|
|
ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð ºê·ëÀÇ ±â´ëÀÌ·Ð(expectancy theory)Àº µ¿±âºÎ¿©ÀÌ·Ð Áß¿¡¼ °¡Àå ³Î¸® ¼ö¿ëµÇ´Â ÀÌ·ÐÀ¸·Î, `¸ðƼº£À̼Ç.. / ºê·ë(Vroom)ÀÇ ±â´ëÀÌ·Ð ºê·ëÀÇ ±â´ëÀÌ·Ð(expectancy theory)Àº µ¿±âºÎ¿©ÀÌ·Ð Áß¿¡¼ °¡Àå ³Î¸® ¼ö¿ëµÇ´Â ÀÌ·ÐÀ¸·Î, `¸ðƼº£ÀÌ¼Ç Á¤µµ´Â ÇàÀ§ÀÇ °á°ú¿¡ ´ëÇÑ ¸Å·ÂÀÇ Á¤µµ(À¯ÀǼº)¿Í °á°úÀÇ °¡´É¼º(±â´ë), ±×¸®°í ¼º°ú¿¡ ´ëÇÑ º¸»ó°¡´É¼º(¼ö´Ü¼º)ÀÇ ÇÔ¼ö¡¦ |
|
|
|
|
|
»çÀ̹ö Âü°íÁ¤º¸¿ø ½Ã½ºÅÛ ±¸Ãà VRRS ½Ã½ºÅÛ °³¹ß ¼¼ºÎ°èȹ¼ / VRRS ½Ã½ºÅÛ °³¹ß ¼¼ºÎ°èȹ¼- »çÀ̹ö Âü°íÁ¤º¸¿ø ½Ã½ºÅÛ ±¸Ãà- T h e2 n dÁ¦¾È¿äû¿¡ ´ëÇÑ ÀÌÇØ ; 1.»ç¾÷¸ñÇ¥ »ç¾÷ÃßÁø¸ñÇ¥ »çÀ̹ö ¡¦ |
|
|
|
|
|
VR,AR °ÔÀÓÀÇ ¹Ì·¡ / 1. AR,VRÀÇ Á¤ÀÇ 2. AR,VRÀÇ ½ÃÀå±Ô¸ð 3. Vr ±â±â(hmd)ÀÇ ÇöÀç ¹®Á¦Á¡ 4. AR,VR°ÔÀÓÀÇ ÇöȲ 5. ³»°¡ »ý°¢ÇÏ´Â AR,VR°ÔÀÓÀÇ ¹Ì·¡ / 1. AR,VRÀÇ Á¤ÀÇ AR(Áõ° Çö½Ç)°ú VR(°¡»ó Çö½Ç)Àº ÃֽŠ±â¼ú ¹ßÀü°ú ÇÔ²² °ÔÀÓ »ê¾÷ ³»¿¡¼ Å« ÁÖ¸ñÀ» ¹Þ°í ÀÖ´Â Çõ½ÅÀûÀÎ °æÇèÀ» Á¦°øÇÏ´Â ±â¼úÀÌ´Ù. ARÀº Çö½Ç ¼¼°è¿¡ °¡»óÀÇ ¿ä¼Ò¸¦ Áßø½ÃÅ°´Â ±â¼ú·Î, »ç¿ëÀÚ°¡ ½ÇÁ¦ ȯ°æ¡¦ |
|
|
|
|
|
°£È£Çаú]°¨¿°¹Ì»ý¹°]VRE¿ÍMRSA / 1) Á¤ÀÇ 2) ¿ªÇÐ 3) ÀÓ»óÀû ÀÇÀÇ 4) °¨¿°°æ·Î 5) Ä¡·á 6) °Ý¸® 2. MRSAmethicillin resistant staphylococcus aureus, ¸ÞŸ½Ç¸° ³»¼ºÆ÷µµ»ó±¸±Õ / 1) Á¤ÀÇ 2) ¿ªÇÐ 3) º´¿øü ¹× ÀüÆĹæ¹ý 4) Ä¡·á 5) °¨¿°°ü¸® 1. VREvancomycin-resistant enterococci infection, ¹ÝÄÚ¸¶À̽Š³»¼º Àå¾Ë±Õ °¨¿° VRE´Â ¹ÝÄÚ¸¶À̽Š³»¼º Àå¾Ë±Õ °¨¿°À» ÀǹÌÇϸç, ÀÌ¡¦ |
|
|
|
|
|
¸Æµµ³¯µå ¸¶ÀÌŬ Æ÷ÅÍ 5 Forces Analysis ºÐ¼®, VRIN ºÐ¼® / 1. Overview 2. 5 Forces Analysis of McDonald¡¯s 1) Competition among Existing Competitors 2) Treat of New Entrants 3) Treat of Substitue 4) Power of Suppliers 5) Power of Buyers 3. Core Resource Analysis 4. Strategic Suggestions / 1. Overview ¸Æµµ³¯µå´Â ¼¼°è¿¡¼ °¡Àå Àß ¾Ë·ÁÁø ÆнºÆ®Çªµå ºê·£¡¦ |
|
|
|
|
|
½Å±¸´ëÇб³ VR°ÔÀÓÄÜÅÙÃ÷°ú3³âÁ¦ Çо÷°èȹ¼ ¿¬±¸°èȹ¼ ÀÚ±â¼Ò°³¼ / 1.ÁøÇе¿±â ½Å±¸´ëÇб³ VR°ÔÀÓÄÜÅÙÃ÷°ú¿¡ ÁøÇÐÇÏ°íÀÚ ÇÏ´Â ÀÌÀ¯´Â °¡»óÇö½Ç ±â¼úÀÇ Çõ½ÅÀûÀÎ ÀáÀç·Â¿¡ ¸Å·áµÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ¾î¸° ½ÃÀýºÎÅÍ °ÔÀÓÀ» »ç¶ûÇϸç ÀÚ¶ó¿Â Àú¿¡°Ô °ÔÀÓÀº ´Ü¼øÇÑ ¿À¶ôÀ» ³Ñ¾î, »õ·Î¿î ¼¼°è¸¦ üÇèÇÏ°í ´Ù¾çÇÑ °¨Á¤À» ´À³¥ ¼ö ÀÖ´Â ¸Å°³Ã¼¿´½À´Ï´Ù. VR ±â¼úÀÌ Àû¿ëµÈ °ÔÀÓµéÀº ±× °¡´É¼º¡¦ |
|
|
|
|
|
ÃÖÁ¾ ÇÕ°Ý ½Å±¸´ëÇб³ VR°ÔÀÓÄÜÅÙÃ÷°ú3Á¦ Çо÷°èȹ¼ / 1.Áö¿øµ¿±â ¹× Àå·¡°èȹ VR °ÔÀÓ ÄÜÅÙÃ÷¿¡ ´ëÇÑ ±íÀº °ü½ÉÀº ¾î¸± ÀûºÎÅÍ ½ÃÀ۵Ǿú½À´Ï´Ù. ´Ù¾çÇÑ °ÔÀÓÀ» °æÇèÇÏ¸é¼ ±× ¾È¿¡ ¼û°ÜÁø ½ºÅ丮¿Í °¨Á¤À» Àü´ÞÇÏ´Â ¹æ½Ä¿¡ ¸Å·áµÇ¾ú°í, ƯÈ÷ VRÀ̶ó´Â ±â¼úÀÌ »ç¿ëÀÚ¿¡°Ô ¸ôÀÔ°¨À» Á¦°øÇÏ´Â Á¡¿¡ Å©°Ô Èï¹Ì¸¦ ´À²¼½À´Ï´Ù. ½Å±¸´ëÇб³ÀÇ VR °ÔÀÓ ÄÜÅÙÃ÷°ú´Â Çõ½ÅÀûÀÌ°í ½Ç¿ëÀûÀÎ Ä¿¸®Å§¡¦ |
|
|
|
|